Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2000
11/16/2000CA2372704A1 Use of phthalazine derivatives
11/16/2000CA2369333A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
11/16/2000CA2369323A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/15/2000EP1052285A2 Method of inducing an antigen-specific anticytotoxic cell
11/15/2000EP1051976A2 Use of bisphosphate for the treatment of osteogenesis imperfecta
11/15/2000EP1051975A1 Dry mix formulation for bisphosphonic acids
11/15/2000EP1051521A2 Method of screening therapeutic agents
11/15/2000EP1051511A1 Methods of identifying modulators of kinases responsive to stress
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051431A1 Thrombin inhibitors
11/15/2000EP1051407A1 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
11/15/2000EP1051403A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/15/2000EP1051395A1 Hydroxamic and carboxylic acid derivatives
11/15/2000EP1051176A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/15/2000CN1273529A Vitronection receptor antagonist
11/15/2000CN1273124A Powder prepared with colophony, realgar and 'Huangdan'
11/15/2000CN1273109A Chinese medicine for treating bone fracture and injury
11/15/2000CN1273106A Fumigating mixture of liquid and powder for bone setting and fumigating bed with stepless regulation of heat
11/15/2000CN1273102A Oral liquid for treating rheumatic and rheumatoid arthritides
11/15/2000CN1273101A Thermal picking for recovery of hyperosteogeny and protrusion of intervertebral disc
11/15/2000CN1058409C Medicine for treatment of osteoproliferation
11/14/2000US6147250 Treating diseases mediated by vascular cell adhesion molecule-1, including cardiovascular and inflammatory diseases; succinobucol
11/14/2000US6147186 Receptor agonist for treating osteoporosis
11/14/2000US6147096 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
11/14/2000US6147092 Method for inhibiting estrogen-dependent cancer
11/14/2000US6147082 Chalcones having antiproliferative activity
11/14/2000US6147080 Inhibitors of p38
11/14/2000US6147074 Arylsulfonylamino hydroxamic acid derivatives
11/14/2000US6147071 Tachykinin receptor antagonist
11/14/2000US6147064 Oral 1α-hydroxyprevitamin D in composition and method for treating psoriasis
11/14/2000US6146876 22025, a novel human cyclic nucleotide phosphodiesterase
11/14/2000CA2179207C Parathyroid hormone formulation
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066613A1 Bone targeting agents for osteoporosis
11/09/2000WO2000066612A1 Androgen glycosides and androgenic activity thereof
11/09/2000WO2000066599A1 Antioxidative vitamin b6 analogs
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066567A1 Pyrimidinone compounds
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066559A1 Piperidine derivatives useful as ccr5 antagonists
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066177A1 GENE THERAPY USING TGF-$g(b)
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066144A2 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066107A2 Antimalarian agents for the treatment of asthma
11/09/2000WO2000066106A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066102A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000WO2000051968A8 Method for the preparation of a chiral-beta-amino ester
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000035906A3 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
11/09/2000WO2000019989A3 Use of catechol derivatives as proteinase inhibitors
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2373045A1 Gene therapy using tgf-.beta.
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372790A1 Monthly doses for treatment of streptococcus pneumonia infections
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371653A1 Antioxidative vitamin b6 analogs
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/08/2000EP1049773A1 Inhibition of cytokine production
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049717A2 Antibodies against human il-12
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049472A1 Antagonists of gonadotropin releasing hormone
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0652872B1 Optically pure magnesium -salt of pyridinylmethyl sulfinyl-1h-benzimidazole compound
1 ... 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 ... 820